Armephaco JSC

Armephaco JSC Stock-Based Compensation

Stock-Based Compensation (SBC) of Armephaco JSC (AMP.VN) as of Oct 19, 2026.

Stock-Based Compensation

-VND

Last updated:

Stock-Based Compensation (SBC) of Armephaco JSC is 2026 - VND. Stock-Based Compensation (SBC) of Armephaco JSC was 2025 - VND. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Armephaco JSC Stock analysis

What does Armephaco JSC do? Armephaco JSC, listed on the Vietnamese stock market with ticker AMP.VN and ISIN VN000000AMP7, is headquartered in Hanoi, Vietnam. The company went public through an IPO on January 12, 2017. Armephaco engages in the manufacture and distribution of pharmaceutical products and medical equipment. Its product range includes glucose meters, sphygmomanometers, hospital beds, medical examination tables, and syringe destroyers. The company also produces and trades a variety of medicines, such as antibiotics, vitamins, pain relievers, antipyretics, gastrointestinal treatments, and anti-allergic medications. Armephaco operates within the pharmaceutical and medical equipment sector, though specific industry classifications are not detailed. The company's website is http://armephaco.com.vn/. As a publicly traded entity, Armephaco provides healthcare-related products and services to the Vietnamese market, focusing on both medical devices and pharmaceuticals. The company's operations are centered in Hanoi, where it manages its manufacturing and distribution activities. No additional details regarding founding year, key personnel, acquisitions, or financial figures are provided in the available information. Armephaco JSC is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Armephaco JSC stock

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Armephaco JSC since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Armephaco JSC historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Armephaco JSC

All Key Metrics — Armephaco JSC